Characterization of MV derived from sera of head and neck squamous cell carcinoma (HNSCC) patients and ascites from ovarian carcinoma patients demonstrates increased expression of IL-10, TGFβ, and Fas ligand (FasL) (49). This evidence concerns the gene IL10 and head and neck squamous cell carcinoma.